This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Meta warns of potential 'material loss' on eve of US addictive design trials

By Mike Swift ( January 29, 2026, 00:41 GMT | Insight) -- As Meta Platforms faces key trials in California and New Mexico in February on allegations that the addictive design of Facebook and Instagram caused a mental health crisis among US teens, the company's leadership repeated warnings that Meta risks "a material loss" in the outcome of the trials. Meanwhile, Meta said that its agreement with the European Commission for less-personalized ads could cause revenue "headwinds" in Europe. Mark Zuckerberg said it would be hard to imagine a world, "in several years, where most glasses that people wear aren't AI glasses."On the threshold of a year of high-stakes trials, Meta Platforms repeated a warning Wednesday that it risks “a material loss” as it defends allegations that the addictive design of Facebook and Instagram drove a youth mental health crisis in the US....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login